<DOC>
	<DOC>NCT00289874</DOC>
	<brief_summary>This is a 3-week study to evaluate FEV1 following treatment with drugs in persistent asthma which is also active during allergy seasons in pediatric patients with seasonal aeroallergen sensitivity.</brief_summary>
	<brief_title>Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Male and female patients, ages 6 to 14 years, with persistent asthma that is also active during allergy season Patients must demonstrate positive skin prick tests to seasonally relevant geographic aeroallergens Patient cannot have any other acute or chronic pulmonary disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>